mdxhealth

MDxHealth is a commercial-stage precision diagnostics company founded in 2003, focused on developing advanced molecular diagnostic solutions for cancer assessment and personalized treatment. With CLIA-certified laboratories in California and Texas, and its European headquarters in Belgium, the company is dedicated to improving patient care through non-invasive and cost-effective urologic solutions. The company specializes in precision diagnostics for early prostate cancer detection and other urologic diseases, utilizing proprietary genetic and epigenetic technologies. MDxHealth offers Clinical Molecular Diagnostics solutions, including prostate cancer genomic testing, the ConfirmMDx for Prostate Cancer product, and urinary tract infection testing services. The company serves urologists, pathologists, and other healthcare professionals, establishing itself as a leader in the field of precision diagnostics.